Clinical Trial Update: Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis. [Phase 2]

View source ↗

Summary

Phase 2 trial update on the efficacy and safety of AAE581 in postmenopausal women with osteopenia or osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis

Drugs mentioned

• AAE581

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED